The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 20, 2021
Filed:
Oct. 23, 2017
Applicant:
Janssen Sciences Ireland Unlimited Company, County Cork, IE;
Inventors:
Harshad Patankar, Raritan, NJ (US);
Nicolaas Martha Felix Goyvaerts, Beerse, BE;
Gopal Rajan Ranga Rajan, Beerse, BE;
Assignee:
Janssen Sciences Ireland Unlimited Company, Cork, IE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61P 31/18 (2006.01); A61K 9/20 (2006.01); A61K 31/505 (2006.01); A61K 45/06 (2006.01); A61P 43/00 (2006.01); A61P 37/04 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0056 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2077 (2013.01); A61K 31/505 (2013.01); A61K 45/06 (2013.01); A61P 31/18 (2018.01); A61P 37/04 (2018.01); A61P 43/00 (2018.01);
Abstract
The present invention is concerned with dispersible compositions comprising rilpivirine or a pharmaceutically acceptable acid addition salt thereof as an active ingredient. Such compositions are useful in the treatment of HIV infection and their dispersibility properties lend themselves to be useful in particular amongst the pediatric or geriatric population.